Delaware General Assembly


CHAPTER 61

FORMERLY

SENATE BILL NO. 24

AS AMENDED BY

SENATE AMENDMENT NO. 1

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO MEDICAL MARIJUANA.

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:

Section 1. Amend § 4902A, Title 16 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline and redesignating accordingly as follows:

§ 4902A. Definitions.

In this chapter, unless the context otherwise requires, the following definitions shall apply:

(3) "Debilitating medical condition'' means 1 or more of the following:

a. Terminal illness, cancer, positive status for human immunodeficiency virus, acquired immune  deficiency syndrome, decompensated cirrhosis, amyotrophic lateral sclerosis, agitation of Alzheimer's disease,  post -traumatic stress disorder, intractable epilepsy, seizure disorder, or the treatment of these  conditions;  conditions.

b. A chronic or debilitating disease or medical condition or its treatment that produces 1 or more of the  following: cachexia or wasting syndrome; severe, debilitating  pain,  pain  that has not responded to previously  prescribed medication or surgical measures for more than 3 months or for which other treatment options produced  serious side effects; intractable nausea; seizures; severe and persistent muscle spasms, including  but not limited to  those characteristic of multiple  sclerosis;  sclerosis.

c. Any other medical condition or its treatment added by the Department, as provided for in § 4906A of this title.

(12) "Physician'' means a properly licensed physician subject to Chapter 17 of Title 24 except as otherwise provided in this paragraph. If the qualifying patient's debilitating medical condition is post-traumatic stress disorder, the physician must also be a licensed psychiatrist. If the qualifying patient is younger than 18 years of age, the physician must be a pediatric neurologist, pediatric gastroenterologist, pediatric oncologist or pediatric palliative care specialist.

Approved July 12, 2017